Drug intelligence / Profile preview

prothrombin complex concentrate (human)

Development stage
Approved
Lead developer
Sinopharm
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Prothrombin complex concentrate (human) is a plasma-derived biologic product containing a concentrated blend of vitamin K-dependent blood coagulation factors, specifically factors II (prothrombin), VII, IX, and X. It is primarily indicated for the urgent reversal of acquired coagulation factor deficiency induced by vitamin K antagonist (VKA, e.g., warfarin) therapy in adult patients with acute major bleeding or a need for urgent surgery or other invasive procedures. Additionally, it is used for the treatment and prophylaxis of bleeding in patients with hemophilia B (congenital factor IX deficiency), particularly when purified factor IX concentrates are not available. The product works by replenishing the depleted clotting factors necessary to restore the coagulation cascade and achieve hemostasis. It is typically administered via slow intravenous injection. Sinopharm Group Shanghai Blood Products Co., Ltd. is developing a version of this product specifically for the treatment of hemophilia B.

Brand names
KcentraBeriplexOctaplexCofact
Other names
human prothrombin complex4-factor PCCPCChuman coagulation factor II, VII, IX, and X complex
02

Targets

F (Coagulation factors)

Beyond the preview

Go deeper on prothrombin complex concentrate (human).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prothrombin complex concentrate (human).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call